Angharad Davis - Concepedia

Author

Angharad Davis

University College London ORCID

Also Known As

A DAVIS, A Davis, A. Davis, Angeline Suma Davis, Angharad Davis, Angharad G Davis, Angharad G. Davis, Davis, Angharad

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University College London University of Cape Town The Francis Crick Institute Imperial College London Wellcome Centre for Infectious Diseases Research in Africa

About

Angharad Davis is an author at University College London specializing in medicine, bacterial meningitis, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	170
2	Health Sciences	4	4	133
3	Clinical Immunology	2	2	41
4	Social Sciences	1	1	45
5	Allergy	1	1	27

Angharad Davis

Publications

604

Citations

H-Index

Page 1

	Year	Citations
Proprioceptive integration and body representation: insights into dancers’ expertise Corinne Jola, Angharad Davis, Patrick Haggard Experimental Brain Research Physical ActivityKinesiologyDanceMotor SkillProprioceptive Integration	2011	85
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy Gavin Giovannoni, Mónica Marta, Angharad Davis, Practical Neurology RheumatologyTranslational MedicineDisease ProgressionClinical TranslationSystemic Treatment	2016	50
Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward Joseph Donovan, Fiona V Cresswell, Nguyễn Thụy Thương Thương, Clinical Infectious Diseases	2020	46
Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis Angharad Davis, Sam Nightingale, Priscilla Springer, Wellcome Open Research Neuropsychological FunctioningNeuropsychologyNeurological FunctioningBacterial MeningitisNeurological Disorder	2019	45
Change practice now! Using atraumatic needles to prevent post lumbar puncture headache Angharad Davis, Ruth Dobson, S. Kaninia, European Journal of Neurology	2013	41
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa Elsa Du Bruyn, Cari Stek, Remi Daroowala, Nature Communications	2023	39
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial Sean Wasserman, Angharad Davis, Cari Stek, Antimicrobial Agents and Chemotherapy	2021	37
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial Angharad Davis, Sean Wasserman, Cari Stek, Clinical Infectious Diseases	2022	37
Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics Fiona V Cresswell, Angharad Davis, Kusum Sharma, Wellcome Open Research	2021	35
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial Thomas Maitre, Maryline Bonnet, Alexandra Calmy, Trials	2022	35

Page 1